Super Vilitra is a combination medication containing Vardenafil (20 mg) and Dapoxetine (60 mg), used primarily to treat erectile dysfunction (ED) and premature ejaculation (PE) in men. The maximum recommended dosage of Super Vilitra is one tablet per 24 hours. Exceeding this dosage increases the risk of serious side effects, such as dizziness, prolonged erection (priapism), fainting, nausea, and cardiovascular complications.
Vardenafil, the PDE5 inhibitor in Super Vilitra, improves blood flow to the penis, enabling an erection when sexually stimulated. Dapoxetine, a selective serotonin reuptake inhibitor (SSRI), works to delay ejaculation. This dual-action formulation is intended for adult men and should only be taken under medical supervision.
The medication should be taken 30 to 60 minutes before anticipated sexual activity, with or without food, but it’s best to avoid heavy or fatty meals which may delay its effectiveness. Alcohol and recreational drugs should also be avoided while using Super Vilitra, as they can intensify side effects.
Patients with pre-existing medical conditions—especially heart, liver, or kidney disorders—should consult a healthcare provider before use. Do not increase the dosage to enhance effects, as it will not improve results and may cause harm. Always follow the prescribing doctor’s guidance.
Français
